M1FG
GILD icon

Mach-1 Financial Group’s Gilead Sciences GILD Stock Holding History

Mach-1 Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,841
Closed -$845K – 293
2022
Q4 		$845K Buy
+9,841
New +$779K 0.28% 69
2022
Q1 		– Sell
-58
Closed -$4K – 247
2021
Q4 		$4K Buy
+58
New +$4K ﹤0.01% 167

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mach-1 Financial Group's GILD Position: Q1 2023 in Review

Mach-1 Financial Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 9,841 shares — an estimated $845K sold.

Mach-1 Financial Group first reported a position in GILD in Q4 2021 and held it in 2 quarters. The position peaked at $845K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Mach-1 Financial Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Mach-1 Financial Group sold 9,841 Gilead Sciences shares in Q1 2023, an estimated $845K.
  • Mach-1 Financial Group first reported a position in Gilead Sciences in Q4 2021 and held it in 2 quarters.
  • Mach-1 Financial Group's Gilead Sciences position peaked at $845K in Q4 2022.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Mach-1 Financial Group's 13F filing for Q1 2023, filed 10 May 2023.